Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Benzo(a)pyrene | 1 | 2024 | 4 | 0.890 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2024 | 7 | 0.880 |
Why?
|
| Employment | 1 | 2021 | 49 | 0.680 |
Why?
|
| Medication Adherence | 1 | 2021 | 48 | 0.670 |
Why?
|
| Veterans | 1 | 2021 | 69 | 0.650 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 89 | 0.640 |
Why?
|
| Signal Transduction | 2 | 2024 | 1454 | 0.580 |
Why?
|
| Brain Ischemia | 3 | 2022 | 87 | 0.480 |
Why?
|
| Pancreatic Neoplasms | 4 | 2022 | 546 | 0.460 |
Why?
|
| Stroke | 3 | 2021 | 256 | 0.400 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 2 | 2022 | 9 | 0.370 |
Why?
|
| Firefighters | 2 | 2022 | 8 | 0.370 |
Why?
|
| Air Pollutants, Occupational | 2 | 2022 | 14 | 0.360 |
Why?
|
| Occupational Exposure | 2 | 2022 | 28 | 0.360 |
Why?
|
| Cachexia | 2 | 2022 | 53 | 0.350 |
Why?
|
| Humans | 27 | 2024 | 28581 | 0.340 |
Why?
|
| Diabetes, Gestational | 2 | 2022 | 68 | 0.340 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2022 | 59 | 0.330 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 215 | 0.270 |
Why?
|
| Transcriptome | 2 | 2024 | 214 | 0.240 |
Why?
|
| Interferon-beta | 2 | 2022 | 40 | 0.220 |
Why?
|
| Hydrocephalus | 2 | 2022 | 55 | 0.220 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2024 | 35 | 0.210 |
Why?
|
| Thrombectomy | 2 | 2020 | 28 | 0.200 |
Why?
|
| Amino Acids | 2 | 2022 | 85 | 0.200 |
Why?
|
| Parabens | 1 | 2022 | 5 | 0.190 |
Why?
|
| Metabolomics | 2 | 2022 | 87 | 0.190 |
Why?
|
| Acetate-CoA Ligase | 1 | 2022 | 9 | 0.190 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 39 | 0.180 |
Why?
|
| Lung Injury | 1 | 2022 | 32 | 0.180 |
Why?
|
| Communicable Diseases | 1 | 2022 | 20 | 0.180 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2022 | 42 | 0.180 |
Why?
|
| Influenza A virus | 1 | 2022 | 37 | 0.180 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2022 | 40 | 0.180 |
Why?
|
| Antigens, CD | 1 | 2022 | 140 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 79 | 0.180 |
Why?
|
| Pneumonia | 1 | 2022 | 89 | 0.180 |
Why?
|
| Fires | 1 | 2021 | 12 | 0.170 |
Why?
|
| Arsenicals | 1 | 2021 | 5 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2022 | 78 | 0.170 |
Why?
|
| Arsenic | 1 | 2021 | 19 | 0.170 |
Why?
|
| MicroRNAs | 2 | 2022 | 301 | 0.170 |
Why?
|
| Cell Plasticity | 1 | 2021 | 10 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 155 | 0.170 |
Why?
|
| Adenosine | 1 | 2021 | 33 | 0.170 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 63 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 121 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2022 | 92 | 0.170 |
Why?
|
| Solute Carrier Organic Anion Transporter Family Member 1B3 | 1 | 2021 | 17 | 0.170 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2021 | 26 | 0.170 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 141 | 0.170 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 1338 | 0.170 |
Why?
|
| Cigarette Smoking | 1 | 2022 | 82 | 0.170 |
Why?
|
| Endometrial Neoplasms | 1 | 2022 | 189 | 0.170 |
Why?
|
| Zinc | 1 | 2021 | 63 | 0.160 |
Why?
|
| Mental Health | 1 | 2021 | 110 | 0.160 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 115 | 0.160 |
Why?
|
| Hepatocytes | 1 | 2021 | 80 | 0.160 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 117 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 121 | 0.160 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2019 | 4 | 0.160 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 16 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 29 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 163 | 0.160 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 300 | 0.160 |
Why?
|
| Disease Management | 1 | 2020 | 90 | 0.150 |
Why?
|
| Pilot Projects | 4 | 2022 | 458 | 0.150 |
Why?
|
| Smokers | 1 | 2020 | 128 | 0.150 |
Why?
|
| Cell Movement | 1 | 2021 | 373 | 0.150 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 71 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 123 | 0.150 |
Why?
|
| DNA Damage | 1 | 2019 | 151 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2022 | 485 | 0.140 |
Why?
|
| Models, Biological | 1 | 2021 | 468 | 0.140 |
Why?
|
| Biomarkers | 4 | 2022 | 770 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 404 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 357 | 0.140 |
Why?
|
| Liver | 1 | 2021 | 456 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 285 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2021 | 523 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 834 | 0.130 |
Why?
|
| Brain | 1 | 2021 | 753 | 0.120 |
Why?
|
| Female | 8 | 2022 | 15471 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 595 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2022 | 1272 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 857 | 0.100 |
Why?
|
| Mice | 4 | 2022 | 4732 | 0.090 |
Why?
|
| Muscles | 2 | 2022 | 73 | 0.090 |
Why?
|
| DNA Copy Number Variations | 2 | 2022 | 36 | 0.090 |
Why?
|
| Cerebral Infarction | 2 | 2022 | 26 | 0.090 |
Why?
|
| Risk Factors | 3 | 2022 | 2111 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2022 | 2612 | 0.090 |
Why?
|
| Animals | 5 | 2022 | 10580 | 0.080 |
Why?
|
| Male | 6 | 2022 | 13771 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2021 | 2402 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2022 | 732 | 0.080 |
Why?
|
| Lung | 2 | 2022 | 380 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 480 | 0.080 |
Why?
|
| Middle Aged | 4 | 2021 | 7310 | 0.070 |
Why?
|
| Pregnancy | 2 | 2022 | 1219 | 0.070 |
Why?
|
| Prognosis | 2 | 2020 | 807 | 0.070 |
Why?
|
| Phenol | 1 | 2022 | 7 | 0.050 |
Why?
|
| Dynamin II | 1 | 2022 | 13 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2022 | 15 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2022 | 21 | 0.050 |
Why?
|
| Dextrans | 1 | 2022 | 23 | 0.050 |
Why?
|
| Syndecan-1 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Phenols | 1 | 2022 | 22 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2022 | 42 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2022 | 23 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2022 | 82 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2022 | 34 | 0.050 |
Why?
|
| Receptors, Growth Factor | 1 | 2022 | 7 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 29 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 100 | 0.050 |
Why?
|
| Blood Volume | 1 | 2022 | 8 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2022 | 66 | 0.050 |
Why?
|
| Sphingolipids | 1 | 2022 | 20 | 0.050 |
Why?
|
| Cyclin D1 | 1 | 2022 | 38 | 0.050 |
Why?
|
| Hospitals | 1 | 2022 | 77 | 0.050 |
Why?
|
| Lysosomes | 1 | 2022 | 56 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2022 | 90 | 0.040 |
Why?
|
| Tobacco | 1 | 2022 | 87 | 0.040 |
Why?
|
| China | 1 | 2021 | 61 | 0.040 |
Why?
|
| Research | 1 | 2022 | 93 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2021 | 36 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 102 | 0.040 |
Why?
|
| Cacodylic Acid | 1 | 2021 | 5 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2021 | 39 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 24 | 0.040 |
Why?
|
| Sincalide | 1 | 2021 | 4 | 0.040 |
Why?
|
| Language | 1 | 2021 | 65 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 93 | 0.040 |
Why?
|
| Integrin alpha3 | 1 | 2021 | 18 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 95 | 0.040 |
Why?
|
| Brain Infarction | 1 | 2020 | 10 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 70 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 57 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 214 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 144 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2021 | 68 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2021 | 153 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2021 | 53 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 226 | 0.040 |
Why?
|
| Infarction | 1 | 2020 | 8 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 192 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 190 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2021 | 118 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 288 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2021 | 60 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 164 | 0.040 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2020 | 26 | 0.040 |
Why?
|
| African Americans | 1 | 2022 | 352 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Vasospasm, Intracranial | 1 | 2020 | 18 | 0.040 |
Why?
|
| Histone Deacetylase 2 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 37 | 0.040 |
Why?
|
| Survivors | 1 | 2020 | 40 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 378 | 0.040 |
Why?
|
| Aged | 2 | 2020 | 5525 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 48 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2019 | 19 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2020 | 56 | 0.040 |
Why?
|
| Registries | 1 | 2022 | 393 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 265 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 50 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 155 | 0.040 |
Why?
|
| Histones | 1 | 2019 | 95 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 461 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2021 | 160 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 144 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2020 | 273 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 815 | 0.040 |
Why?
|
| Prevalence | 1 | 2020 | 510 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2019 | 581 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 426 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 467 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 465 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 734 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 641 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 1026 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 1601 | 0.030 |
Why?
|
| Smoking | 1 | 2020 | 476 | 0.030 |
Why?
|
| Child | 1 | 2022 | 2271 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2020 | 631 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2045 | 0.030 |
Why?
|
| Adult | 1 | 2020 | 7922 | 0.020 |
Why?
|